Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Belgian PM receives implant his govt has restricted:

This article was originally published in Clinica

Executive Summary

The lack of reimbursement in Belgium for drug-eluting stents has been highlighted following the Belgian Prime Minister, Guy Verhofstadt, requiring such an implant during an emergency operation on March 30. In Belgium, drug-eluting stents are only reimbursed for patients who are diabetic. With the Belgian healthcare system under the pressure because of escalating costs (see next week's issue), it seems unlikely that the government will change its policy over drug-eluting stents, although the Prime Minister may find himself having to answer some difficult questions.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel